After eight years at CCA Advertising, Mike Devlin has left to join Concentric Advertising, as head of its new pharma consumer shop.
This follows some of the general shuffling that’s taken place at CCA Advertising since inVentiv’s $65 million buyout of the company. Some report that CCA is pushing much of its consumer work under its [...]

[Read more →]

If you follow any news from the HIV/AIDS market at all, no doubt you’re like us—waiting on pins and needles to hear if FDA will approve Tibotec’s non-nucleoside reverse transcriptase inhibitor, TMC125.
The drug was accepted for priority review by FDA, with a PDUFA date of today. I got tired of checking the company’s Web site [...]

[Read more →]

Aren’t Pharm Exec readers lucky? Right now, we’re working on a report for our February issue that draws on a discussion by high-ranking sales executives in the industry. I don’t want to give away too much, but we put together an expert panel about the changing sales model, and there were more than a few [...]

[Read more →]

DTC in Canada may be closer than you think. Currently, Canada allows only reminder and disease-awareness ads for prescription drugs. But while a court case continues to rage challenging the legality of the DTC ban, an industry group is quietly setting up the infrastructure that will help companies implement what may be a more patient-friendly [...]

[Read more →]

Face it: Lots of us have a certain penchant for business books. Whether memorizing the Seven Habits of Highly Effective People or swearing by Seth Godin, we come away from these books ready to organize better, communicate more, etc, etc.…
But Zenobia: A Tale of Triumph Over Yes-People, Cynics, Hedgers, and Other Corporate Killjoys is different—and [...]

[Read more →]